Frequency of measles virus-specific CD4+ and CD8+ T cells in subjects seronegative or highly seropositive for measles vaccine

Clinical and Diagnostic Laboratory Immunology

Volumn 10, Issue 3, 2003, Pages 411-416

  Ovsyannikova, Inna G ^a   Dhiman, Neelam ^a   Jacobson, Robert M ^a   Vierkant, Robert A ^a   Poland, Gregory A ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; IMMUNOGLOBULIN G ANTIBODY; INTERLEUKIN 4; MEASLES MUMPS RUBELLA VACCINE; MEASLES VACCINE;

ADOLESCENT; ADULT; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ARTICLE; CELL PROLIFERATION; CELLULAR IMMUNITY; FEMALE; HUMAN; HUMORAL IMMUNITY; IMMUNITY; IMMUNOLOGY; IMMUNOREACTIVITY; INTERFERON PRODUCTION; LYMPHOCYTE ACTIVATION; MALE; MEASLES VACCINATION; MEASLES VIRUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; SERODIAGNOSIS; T LYMPHOCYTE; TH1 CELL; TH2 CELL; VACCINATION; VIROLOGY;

ADOLESCENT; ADULT; ANTIBODY FORMATION; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; FEMALE; HUMANS; IMMUNITY; IMMUNITY, CELLULAR; INTERFERON TYPE II; INTERLEUKIN-4; LYMPHOCYTE ACTIVATION; MALE; MEASLES VACCINE; MEASLES VIRUS; VACCINATION;

EID: 0037957138     PISSN: 1071412X     EISSN: None     Source Type: Journal    
DOI: 10.1128/CDLI.10.3.411-416.2003     Document Type: Article

References (37)

1. Albrecht, P., K. Herrmann, and G. R. Burns. 1981. Role of virus strain in conventional and enhanced measles plaque neutralization test. J. Virol. Methods 3:251-260.
2. Anders, J. F., R. M. Jacobson, G. A. Poland, S. J. Jacobsen, and P. C. Wollan. 1996. Secondary failure rates of measles vaccines: a meta-analysis of published studies. Pediatr. Infect. Dis. J. 15:62-66.
3. Asemissen, A. M., D. Nagorsen, U. Keilholz, A. Letsch, A. Schmittel, E. Thiel, and C. Scheibenbogen. 2001. Flow cytometric determination of intracellular or secreted IFNγ for the quantification of antigen reactive T cells. J. Immunol. Methods 251:101-108.
4. Bautista-L6pez, N., B. J. Ward, E. Mills, D. McCormick, N. Martel, and S. Ratnam. 2000. Development and durability of measles antigen-specific lymphoproliferative response after MMR vaccination. Vaccine 18:1393-1401.
5. Bercovici, N., M. T. Duffour, S. Agrawal, M. Salcedo, and J. P. Abastado. 2000. New methods for assessing T-cell responses. Clin. Diagn. Lab. Immunol. 7:859-864.
6. Boteler, W. L., P. M. Luipersbeck, D. A. Fuccillo, and A. J. O'Beirne. 1983. Enzyme-linked immunosorbent assay for detection of measles antibody. J. Clin. Microbiol. 17:814-818.
7. Brunell, P. A. 1990. Measles control in the 1990s: measles serology. World Health Organization, Geneva, Switzerland.
8. Brunell, P. A., K. Weigle, D. Murphy, Z. Shehab, and E. Cobb. 1983. Antibody response following measles-mumps-rubella vaccine under conditions of customary use. JAMA 250:1409-1412.
9. Carter, L. L., and S. L. Swain. 1997. Single cell analyses of cytokine production. Curr. Opin. Immunol. 9:177-182.
10. Cremer, N. E., C. K. Cossen, G. Shell, J. Diggs, D. Gallo, and N. J. Schmidt. 1985. Enzyme immunoassay versus plaque neutralization and other methods for determination of immune status to measles and varicella-zoster viruses and versus complement fixation for serodiagnosis of infections with those viruses. J. Clin. Microbiol. 21:869-874.
11. de Souza, V. A., C. S. Pannuti, L. M. Sumita, and H. F. Andrade, Jr. 1997. Enzyme-linked immunosorbent assay-IgG antibody avidity test for single sample serologic evaluation of measles vaccines. J. Med. Virol. 52:275-279.
12. Feldman, S. B., M. Ferraro, H.-M. Zheng, N. Patel, S. Gould-Fogerite, and P. Fitzgerald-Bocarsly. 1994. Viral induction of low frequency interferon-a producing cells. Virology 204:1-7.
13. Gans, H., L. Yasukawa, M. Rinki, R. DeHovitz, B. Forghani, J. Beeler, S. Audet, Y. Maldonado, and A. M. Arvin. 2001. Immune responses to measles and mumps vaccination of infants at 6, 9, and 12 months. J. Infect. Dis. 184:817-826.
14. Gans, H. A., Y. Maldonado, L. L. Yasukawa, J. Beeler, S. Audet, M. M. Rinki, R. DeHovitz, and A. M. Arvin. 1999. IL-12, IFNγ, and T cell proliferation to measles in immunized infants. J. Immunol. 162:5569-5575.
15. Good, R. A., and S. J. Zak. 1956. Disturbances in gamma globulin synthesis as "experiments of nature." Pediatrics 18:109-149.
16. Griffin, D. E., and W. J. Bellini. 1996. Measles virus, p. 1267-1312. In B. N. Fields, D. M. Knipe, and P. M. Howley (ed.), Fields virology, 3rd ed. Lippincott-Raven Publishers, Philadelphia, Pa.
17. Griffin, D. E., B. J. Ward, E. Jauregui, R. T. Johnson, and A. Vaisberg. 1990. Immune activation during measles: interferon-gamma and neopterin in plasma and cerebrospinal fluid in complicated and uncomplicated disease. J. Infect. Dis. 161:449-453.
18. Jaye, A., A. F. Magnusen, A. D. Sadiq, T. Corrah, and H. C. Whittle. 1998. Ex vivo analysis of cytotoxic T lymphocytes to measles antigens during infection and after vaccination in Gambian children. J. Clin. Investig. 102:1969-1977.
19. Markowitz, L. E., F. W. Chandler, E. O. Roldan, M. J. Saldana, K. C. Roach, S. S. Hutchins, S. R. Preblud, C. D. Mitchell, and G. B. Scott. 1988. Fatal measles pneumonia without rash in a child with AIDS. J. Infect. Dis. 158:480-483.
20. Markowitz, L. E., and M. L. Katz. 1994. Measles vaccine, p. 229-276. In S. A. Plotkin and E. A. Mortimer, Jr. (ed.), Vaccines. The W. B. Saunders Co., Philadelphia, Pa.
21. Markowitz, L. E., S. R. Preblud, P. E. M. Fine, and W. A. Orenstein. 1990. Duration of live measles vaccine-induced immunity. Pediatr. Infect. Dis. J. 9:101-110.
22. Mitus, A., A. Holloway, J. F. Enders, and J. F. Enders. 1965. Attenuated measles vaccine in children with acute leukemia. Am. J. Dis. Child. 103:413-418.
23. Mosmann, T. R. 1991. Cytokine secretion patterns and cross-regulation of T cell subsets. Immunol. Res. 10:183-188.
24. Nanan, R., A. Rauch, E. Kämpgen, S. Niewiesk, and H. W. Kreth. 2000, A novel sensitive approach for frequency analysis of measles virus-specific memory T-lymphocytes in healthy adults with a childhood history of natural measles. J. Gen. Virol. 81:1313-1319.
25. Niewiesk, S., M. Gotzelmann, and V. ter Meulan. 2000. Selective in vivo suppression of T lymphocyte responses in experimental measles virus infection. Proc. Natl. Acad. Sci. USA 97:4251-4255.
26. Orenstein, W. A., K. Herrmann, P. Albrecht, R. Bernier, P. Holmgreen, K. J. Bart, and A. R. Hinman. 1986. Immunity against measles and rubella in Massachusetts schoolchildren. Dev. Biol. Stand. 65:75-83.
27. Poland, G. A., and R. M. Jacobson. 1994. Failure to reach the goal of measles elimination. Apparent paradox of measles infections in immunized persons. Arch. Intern. Med. 154:1815-1820.
28. Poland, G. A., R. M. Jacobson, S. A. Colbourne, A. M. Thampy, J. J. Lipsky, P. C. Wollan, P. Roberts, and S. J. Jacobsen. 1999. Measles antibody seroprevalence rates among immunized Inuit, Innu and Caucasian subjects. Vaccine 17:1525-1531.
29. Preblud, S. R., and S. L. Katz. 1988. Measles vaccine, p. 182-222. In S. A. Plotkin and E. A. Mortimer, Jr. (ed.), Vaccines. The W. B. Saunders Co., Philadelphia, Pa.
30. Ratnam, S., V. Gadag, R. West, J. Burris, E. Oates, F. Stead, and N. Boulianne. 1995. Comparison of commercial enzyme immunoassay kits with plaque reduction neutralization test for detection of measles virus antibody. J. Clin. Microbiol. 33:811-815.
31. Salgame, P., J. S. Abrams, C. Clayberger, H. Goldstein, J. Convit, R. L. Modlin, and B. R. Bloom. 1991. Differing lymphokine profiles of functional subsets of human CD4 and CD8 T cell clones. Science 254:279-282.
32. Samb, B., P. Aaby, H. C. Whittle, A. M. Coll Seck, S. Rahman, J. Bennett, L. Markowitz, and F. Simondon. 1995. Serologic status and measles attack rates among vaccinated and unvaccinated children in rural Senegal. Pediatr. Infect. Dis. J. 14:203-209.
33. Schmittel, A., U. Keilholz, S. Bauer, U. Kuhne, S. Stevanovic, E. Thiel, and C. Scheibenbogen. 2001. Application of the IFN-γ ELISPOT assay to quantify T cell responses against proteins. J. Immunol. Methods 247:17-24.
34. Ward, B. J., N. Boulianne, S. Ratnam, M.-C. Guiot, M. Couillard, and G. De Serres. 1995. Cellular immunity in measles vaccine failure: demonstration of measles antigen-specific lymphoproliferative responses despite limited serum antibody production after revaccination. J. Infect. Dis. 172:1591-1595.
35. Ward, B. J., and D. E. Griffin. 1993. Changes in cytokine production after measles virus vaccination: predominant production of IL-4 suggests induction of a Th2 response. Clin. Immunol. Immunopathol. 67:171-177.
36. Weigle, K. A., M. D. Murphy, and P. A. Brunell. 1984. Enzyme-linked immunosorbent assay for evaluation of immunity to measles virus. J. Clin. Microbiol. 19:376-379.
37. Wharton, M., S. L. Cochi, and W. W. Williams. 1990. Measles, mumps, and rubella vaccines. Infect. Dis. Clin. N. Am. 4:47-73.